Cytek Biosciences (CTKB) Net Income Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.10% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -66.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.05% |
| Dec 31, 2025 | -557.08% |
| Sep 30, 2025 | -672.41% |
| Jun 30, 2025 | 46.24% |
| Mar 31, 2025 | -83.53% |
| Dec 31, 2024 | 76.22% |
| Sep 30, 2024 | 114.82% |
| Jun 30, 2024 | -136.31% |
| Mar 31, 2024 | 9.46% |
| Dec 31, 2023 | 47.18% |
| Sep 30, 2023 | -497.05% |
| Jun 30, 2023 | -526.07% |
| Mar 31, 2023 | -216.96% |
| Dec 31, 2022 | 419.14% |
| Sep 30, 2022 | 14.51% |
| Jun 30, 2022 | -126.29% |
| Mar 31, 2022 | -2,215.69% |
| Dec 31, 2021 | -121.96% |
| Sep 30, 2021 | -78.29% |
| Jun 30, 2021 | -67.08% |